Date: May 22nd (Wednesday)
Time: 3 pm Pacific / 6 pm Eastern
Where: Online Program
GVHD is a potentially life-threatening condition affecting an estimated 50% of blood cancer patients who receive stem cell transplants from a donor. Join us for an informative discussion as transplant experts explain GVHD risks, how to watch for symptoms, the current treatments available, and new clinical trials aimed at prevention and treatment.
Webinar: What You Need to Know About GVHD & Blood Cancer
Learn about GVHD: a Potentially Life-threatening Condition
Program Topics:
- Graft versus Host Disease and the differences between acute and chronic forms
- Preparing for a stem cell transplant and monitoring for GVHD
- The importance of early detection – signs and symptoms of Graft versus Host Disease
- Daily life with GVHD and the realities of new restrictions
- What GVHD clinical trials are available for both prevention and treatment
- How The Leukemia & Lymphoma Society’s Clinical Trial Support Center can help
This program is brought to you by The Patient Story in partnership with The Leukemia & Lymphoma Society.
Hear from Experts: Prevention, Treatment, and Clinical Trials
Join patient advocate and GVHD Alliance cofounder Meredith Cowden as she shares her experiences with GVHD. Then listen as experts from UChicago Medicine, The Leukemia and Lymphoma Society, and Roswell Park Comprehensive Cancer Center – who are on the front lines of GVHD research and treatment discuss the role clinical trials play in advancing the treatment landscape and what it could mean for you. Discover how to take steps to learn more about clinical trials from a clinical trial nurse navigator.
Dr. Shernan Holtan
Chief of Blood and Marrow Transplantation - Roswell Park Comprehensive Cancer Center
Dr. Satyajit Kosuri
UChicago Medicine
Ashley Giacobbi, DNP, RN, ACNS-BC, AOCNS, OCN
Clinical Trial Nurse Navigator - The Leukemia & Lymphoma Society
Meredith Cowden
Chronic GVHD Patient Advocate + Cofounder GVHD Alliance